| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0167-8140(00)00216-4 |
| P698 | PubMed publication ID | 10927133 |
| P50 | author | Marcel van Herk | Q41478085 |
| P2093 | author name string | H Bartelink | |
| L G Dewit | |||
| E P Jansen | |||
| P2860 | cites work | Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas | Q55484160 |
| Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations. | Q55484946 | ||
| Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. | Q55485347 | ||
| Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. | Q55485813 | ||
| Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. | Q55486986 | ||
| Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme | Q55489464 | ||
| Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial | Q55489648 | ||
| Assumptions in the radiotherapy of glioblastoma | Q55490810 | ||
| Automatic three-dimensional correlation of CT-CT, CT-MRI, and CT-SPECT using chamfer matching | Q61923396 | ||
| MRI-assisted radiation therapy planning of brain tumors--clinical experiences in 17 patients | Q70157263 | ||
| Advances in radiation therapy for brain tumors | Q70957519 | ||
| Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging | Q71933213 | ||
| Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery | Q33483488 | ||
| Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study | Q34239497 | ||
| A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma | Q36045126 | ||
| Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial | Q36046651 | ||
| Studies on high grade cerebral gliomas | Q37876079 | ||
| Radiotherapy for high grade gliomas | Q37913842 | ||
| Radiation therapy for malignant astrocytomas in adults | Q38568238 | ||
| Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. | Q38652757 | ||
| The fallacy of the localized supratentorial malignant glioma | Q39244859 | ||
| An analysis of dose-effect relationship in the radiotherapy of malignant gliomas | Q40285820 | ||
| Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. | Q40677421 | ||
| Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy | Q40720858 | ||
| External beam radiotherapy: hard facts and painful realities | Q40923854 | ||
| Precision radiation therapy for optic nerve sheath meningiomas | Q45932031 | ||
| Radiosurgery for glioma patients: hope or hype? | Q47627667 | ||
| Image fusion for stereotactic radiotherapy and radiosurgery treatment planning | Q48153936 | ||
| Malignant glioma: patterns of failure following individually tailored limited volume irradiation | Q48179804 | ||
| Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas | Q48284279 | ||
| Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials | Q48286137 | ||
| Good performance status of long-term disease-free survivors of intracranial gliomas | Q48300795 | ||
| The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas | Q48404656 | ||
| A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors | Q48420154 | ||
| High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme | Q48491367 | ||
| The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms | Q48549162 | ||
| Magnetic resonance imaging and histopathology of cerebral gliomas | Q48583742 | ||
| Functional imaging in treatment planning of brain lesions. | Q55479050 | ||
| Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma. | Q55481669 | ||
| Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. | Q55483140 | ||
| P433 | issue | 2 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 151-156 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Radiotherapy and Oncology | Q14251029 |
| P1476 | title | Target volumes in radiotherapy for high-grade malignant glioma of the brain | |
| P478 | volume | 56 |
| Q36980379 | 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. |
| Q33215161 | A clinical interactive technique for MR-CT image registration for target delineation of intracranial tumors |
| Q48242156 | A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma |
| Q42968374 | Addition of magnetic resonance imaging to computed tomography-based three-dimensional conformal radiotherapy planning for postoperative treatment of astrocytomas: Changes in tumor volume and isocenter shift |
| Q36339461 | Advances in neuro-oncology imaging. |
| Q37970192 | Advances in radiotherapy: from 2D to 4D. |
| Q38691946 | Amino acid PET and MR perfusion imaging in brain tumours. |
| Q33642508 | Analysis of equivalent uniform dose (EUD) and conventional radiation treatment parameters after primary and re-irradiation of malignant glioma |
| Q31120167 | Characteristics and quality assurance of a dedicated open 0.23 T MRI for radiation therapy simulation |
| Q55463865 | Clinical evaluation of 3D/3D MRI-CBCT automatching on brain tumors for online patient setup verification – A step towards MRI-based treatment planning |
| Q48926151 | Clinical target volume of high-grade glioma |
| Q43743749 | Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas |
| Q44494942 | Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas |
| Q42041284 | Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning. |
| Q38045432 | Current challenges in clinical target volume definition: tumour margins and microscopic extensions |
| Q33487194 | Diagnostics of cerebral gliomas with radiolabeled amino acids |
| Q48118589 | Diffusion tensor magnetic resonance imaging driven growth modeling for radiotherapy target definition in glioblastoma |
| Q38269839 | Evaluation of current clinical target volume definitions for glioblastoma using cell-based dosimetry stochastic methods |
| Q48177906 | External beam and conformal radiotherapy in the management of gliomas |
| Q39670061 | External beam radiotherapy of recurrent glioma: radiation tolerance of the human brain |
| Q89100541 | Generating synthetic CTs from magnetic resonance images using generative adversarial networks |
| Q28075869 | IDH mutations may not preclude distant, trans-tentorial spread in gliomas: a case report and review of the literature |
| Q40596156 | Imaging of gliomas with Cis-4-[18F]fluoro-L-proline. |
| Q46768751 | Improved diagnostics of cerebral gliomas using FET PET |
| Q37455074 | Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison |
| Q37098119 | Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma |
| Q48177863 | Intralesional radioimmunotherapy in the treatment of malignant glioma: clinical and experimental findings |
| Q55461270 | Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study. |
| Q38924520 | Multicentric spinal cord and brain glioblastoma without previous craniotomy. |
| Q37408026 | Multifocal and multicentric glioblastoma with leptomeningeal gliomatosis: a case report and review of the literature |
| Q37284164 | Novel membrane-permeable contrast agent for brain tumor detection by MRI |
| Q37850500 | Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. |
| Q37221207 | Personalized treatment strategies in glioblastoma: MGMT promoter methylation status |
| Q46154560 | Radiation treatment parameters for re-irradiation of malignant glioma |
| Q101476145 | Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy |
| Q64889096 | Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity. |
| Q37037922 | Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume. |
| Q54977184 | Robo1 and vimentin regulate radiation-induced motility of human glioblastoma cells. |
| Q48807653 | Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival |
| Q48986560 | Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas |
| Q36071865 | Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of glioma |
| Q48428540 | Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas |
| Q47267204 | Survival improvements with adjuvant therapy in patients with glioblastoma. |
| Q35177942 | Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review |
| Q61807063 | The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review |
| Q26746622 | The evolving roles and controversies of radiotherapy in the treatment of glioblastoma |
| Q49012148 | The impact of computed tomography slice thickness on the assessment of stereotactic, 3D conformal and intensity-modulated radiotherapy of brain tumors |
| Q61800589 | The increased adhesion of tumor cells to endothelial cells after irradiation can be reduced by FAK-inhibition |
| Q44288866 | What is the best way to evaluate clinical target volume for radiotherapy of brain tumors? |
| Q30838129 | What is the most appropriate clinical target volume for glioblastoma? |
Search more.